Fernando Magro is Associate Professor of Pharmacology and Therapeutics at the University of Porto in Portugal. He is also Director of the Department of Clinical Pharmacology and a consultant gastroenterologist at Centro Hospitalar de São João in Porto, and a member of the board of Portuguese inflammatory bowel disease (IBD) group (GEDII), of which he is a founding member.
Professor Magro was an organizer of three European Crohn’s and Colitis Organisation (ECCO) consensus meetings on: histopathology of IBD; opportunistic infections in IBD; and reproduction and pregnancy. He has published his research in: articles in peer-reviewed journals on basic and clinical science; books; and book chapters. He is Associate Editor of UEG Journal and member of the editorial board of Journal of Crohn’s and Colitis and serves as a reviewer for several specialist journals, including Lancet, Lancet Gastroenterology and Hepatology, Journal of Crohn’s and Colitis, Gut, Gastroenterology, Inflammatory Bowel Diseases, Alimentary Pharmacology and Therapeutics, European Journal of Pharmacology, European Journal of Internal Medicine, and Digestive and Liver Disease.
EM-58759 - Date of preparation: April 2021